Geisinger to Expand Genomics Project to Preventive Care
![geisinger-dna](/sites/default/files/styles/900x400/public/2018-05/geisinger-dna.jpg?itok=1u95W4PZ)
Geisinger will expand its precision medicine project beyond research to preventive care, the Danville, PA-based integrated health system announced Sunday. The project already reports clinically actionable genomic results to research participants and their primary care physicians, and plans to launch a clinical DNA pilot program with 1,000 patients in the next six months. “Understanding the genome warning signals of every patient will be an essential part of wellness planning and health management,” Geisinger President and CEO David Feinberg, M.D., told participants at the HLTH Conference in Las Vegas. “Geisinger patients will be able to work with their family physician to modify their lifestyle and minimize risks that may be revealed.”
Related News Articles
Headline
The Centers for Disease Control and Prevention May 29 published a blog co-authored by AHA, the National Institute for Occupational Safety and Health and the…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…
Blog
Exploring and developing a better understanding of the social determinants of health is becoming standard in medical education and training. Social isolation…
Chairperson's File
In today’s episode, I talk with Lynn Todman, vice president of health equity and community partnerships at Corewell Health. Our discussion focuses on the many…
Blog
As a pediatrician, I've seen the impact of pediatric sepsis firsthand — it's an aggressive and unrelenting adversary that knows neither geographic nor…
Headline
The House Energy and Commerce Health Subcommittee March 12 passed AHA-supported legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care…